Boston Scientific Corp. signed an agreement to purchase a majority stake (64%) of M.I. Tech Co. Ltd. for $230 million. The publicly traded Pyeongtaek South Korea-based company manufactures device solutions used in endoscopic and urologic procedures. Boston Scientific has distributed M.I. Tech’s Hanarostent non-vascular stent in Japan since 2015. The deal marks Boston Scientific’s first acquisition of the year, following a busy spending spree in 2021. Read More
In May, Sidekick Health AB revealed an expanded partnership with New York-based Pfizer Inc. for autoimmune-related conditions. Now, it has joined forces with Eli Lilly and Co. to help patients battling breast cancer with its gamified platform. The companies plan to introduce the integrated digital therapeutic starting in July with the roll out beginning in Germany. Read More
Ibex Medical Analytics Ltd. extended the reach of its artificial intelligence (AI) powered pathology system, adding gastric cancer to existing CE mark approvals in prostate and breast cancer. Read More
The U.S. Department of Justice (DOJ) has kept a close eye on medical technology for a number of years, but the department’s consumer protection branch has often lagged behind other DOJ offices where enforcement is concerned. Read More
The U.K. Medicines and Healthcare Products Regulatory Agency (MHRA) is still considering a drastic overhaul of the 2002 medical device regulatory framework, but may have sent a signal that its new framework won’t deviate too far from established regulatory approaches. The agency reported June 16 that it has signed on with both the International Council for Harmonization (ICH) for drugs and the International Medical Device Regulators Forum (IMDRF) for devices, providing members of both industries with at least some modest confidence that access to the 67 million strong U.K. market won’t suffer from a new set of unique regulatory hurdles. Read More
What was billed as a U.S. Senate Health, Education, Labor and Pensions Committee hearing June 16 to get an update from top government health officials on the nation’s response to COVID-19 was, in reality, a concerted effort to get Republicans in the U.S. Senate to open the checkbook so the Biden administration could fill in the amount for more COVID-19 spending, Ranking Member Richard Burr (R-N.C.) charged as he concluded the hearing. Read More
New hires and promotions in the med-tech industry, including: Eclinical Solutions, Luminelle, Rockley Photonics, Sema4, Seqwell, Tandem Diabetes Care. Read More
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Bonesupport, Dariohealth, Dia Imaging, Diadem, GBS, Hollister, Intelerad, Intelligent Fingerprinting, Kurin, Life Science Biosensor Diagnostics, Magnolia Medical, Pieriandx, Solera Health, Stimwave, Syapse. Read More
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Ascensia Diabetes Care, Imagia Canexia Health, Novarad, Senseonics, Sysmex America. Read More
